{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:03:29Z","timestamp":1790096609178,"version":"4.0.1"},"reference-count":64,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T00:00:00Z","timestamp":1700006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Lentigo maligna (LM) is a melanoma in situ with distinct clinical features and histology. It commonly affects men after the sixth decade of life. Incidence rates of LM have increased based on early 21st century data from different countries; however, data are suboptimal. Data from England show a plateauing crude incidence between 2013 and 2019. By comparison, invasive melanoma and other types of melanoma in\u00a0situ commonly appears in younger age groups (median age 58 and 67\u2005years old, respectively) and incidence is rising. The most important risk factors for LM include fair skin and cumulative ultraviolet solar radiation exposure. Although LM is limited to the epidermis and connected skin adnexa, it may progress to invasive LM melanoma. The reported rate of malignant progression varies, reflecting a challenge for LM epidemiology research as often lesions are removed on diagnosis. LM poses a challenge in diagnosis and management. Although it can be diagnosed clinically or dermoscopically, histopathological assessment of biopsied skin tissue remains the gold standard. Reflectance confocal microscopy allows for better appreciation of the complexity of LM at a cellular level, often progressing beyond clinical margins. Management of LM may involve Mohs micrographic surgery or excision, although recurrence may occur even with 5\u2005mm clinical margins. Imiquimod cream may be effective, but incomplete treatment and recurrence has been reported. Conservative management with observation or radiotherapy may be used in selected patients\u2019 cases. Five-year net survival rates are excellent. This paper reviews the natural history, epidemiology, aetiology, pathogenesis, diagnosis and management of LM.<\/jats:p>","DOI":"10.1093\/ced\/llad394","type":"journal-article","created":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T17:14:33Z","timestamp":1699982073000},"page":"218-225","source":"Crossref","is-referenced-by-count":20,"title":["Lentigo maligna: a review"],"prefix":"10.1093","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8847-7537","authenticated-orcid":false,"given":"Dimitrios","family":"Karponis","sequence":"first","affiliation":[{"name":"Department of Dermatology, Norfolk and Norwich University Hospital , Norwich , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis A","family":"Stratigos","sequence":"additional","affiliation":[{"name":"Norwich Medical School, University of East Anglia , Norwich , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jilse","family":"Joshy","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Norfolk and Norwich University Hospital , Norwich , UK"},{"name":"Norwich Medical School, University of East Anglia , Norwich , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J","family":"Craig","sequence":"additional","affiliation":[{"name":"Cellular Pathology, Gloucestershire Hospitals NHS Foundation Trust , Cheltenham , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4770-9335","authenticated-orcid":false,"given":"Khaylen","family":"Mistry","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Norfolk and Norwich University Hospital , Norwich , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitta","family":"van Bodegraven","sequence":"additional","affiliation":[{"name":"British Association of Dermatologists , London , UK"},{"name":"National Disease Registration Service , Data and Analytics , NHS England, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe C","family":"Venables","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Norfolk and Norwich University Hospital , Norwich , UK"},{"name":"Norwich Medical School, University of East Anglia , Norwich , UK"},{"name":"National Disease Registration Service , Data and Analytics , NHS England, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3393-8305","authenticated-orcid":false,"given":"Nick J","family":"Levell","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Norfolk and Norwich University Hospital , Norwich , UK"},{"name":"Norwich Medical School, University of East Anglia , Norwich , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,11,15]]},"reference":[{"key":"2024021702390485000_llad394-B1","doi-asserted-by":"crossref","first-page":"675296","DOI":"10.3389\/fonc.2021.675296","article-title":"The WHO 2018 classification of cutaneous melanocytic neoplasms: suggestions from routine practice","volume":"11","author":"Ferrara","year":"2021","journal-title":"Front Oncol"},{"key":"2024021702390485000_llad394-B2","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1080\/14737140.2018.1489246","article-title":"The eighth edition American Joint Committee on Cancer (AJCC) melanoma staging system: implications for melanoma treatment and care","volume":"18","author":"Keung","year":"2018","journal-title":"Expert Rev Anticancer Ther"},{"key":"2024021702390485000_llad394-B3","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/j.1365-4632.2008.03696.x","article-title":"Eponyms of Sir Jonathan Hutchinson","volume":"47","author":"van Ruth","year":"2008","journal-title":"Int\u00a0J Dermatol"},{"key":"2024021702390485000_llad394-B4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1001\/archderm.1955.01540250004002","article-title":"Melanotic freckle (Hutchinson), m\u00e9lanose circonscrite pr\u00e9canc\u00e9reuse (Dubreuilh)","volume":"71","author":"Klauder","year":"1955","journal-title":"AMA Arch Derm"},{"key":"2024021702390485000_llad394-B5","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/archderm.1959.01560240105012","article-title":"Melanotic freckle, lentigo maligna","volume":"80","author":"Costello","year":"1959","journal-title":"Arch Dermatol"},{"key":"2024021702390485000_llad394-B6","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/0190-9622(95)90282-1","article-title":"Lentigo maligna and lentigo maligna melanoma","volume":"33","author":"Cohen","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"2024021702390485000_llad394-B7","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/jid.1960.63","article-title":"Melanosis circumscripta praecancerosa (Dubreuilh), a non-nevoid premelanoma distinct from junction nevus","volume":"34","author":"Mishima","year":"1960","journal-title":"J Invest Dermatol"},{"key":"2024021702390485000_llad394-B8","first-page":"39","article-title":"Lentigo maligna and lentigo-maligna melanoma","volume":"55","author":"Clark","year":"1969","journal-title":"Am J Pathol"},{"key":"2024021702390485000_llad394-B9","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2217\/mmt.15.3","article-title":"Lentigo maligna and lentigo maligna melanoma: contemporary issues in diagnosis and management","volume":"2","author":"Connolly","year":"2015","journal-title":"Melanoma Manag"},{"key":"2024021702390485000_llad394-B10","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/CMR.0000000000000619","article-title":"Estimated risk of progression of lentigo maligna to lentigo maligna melanoma","volume":"30","author":"Menzies","year":"2020","journal-title":"Melanoma Res"},{"key":"2024021702390485000_llad394-B11","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2133.1987.tb05843.x","article-title":"The risk of progression of lentigo maligna to lentigo maligna melanoma","volume":"116","author":"Weinstock","year":"1987","journal-title":"Br J Dermatol"},{"key":"2024021702390485000_llad394-B12","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/0002-9394(55)90156-2","article-title":"Precancerous and cancerous melanosis of the conjunctiva","volume":"39","author":"Reese","year":"1955","journal-title":"Am J Ophthalmol"},{"key":"2024021702390485000_llad394-B13","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/bjc.1996.168","article-title":"Comparison between lentigo maligna melanoma and other histogenetic types of malignant melanoma of the head and neck. Scottish Melanoma Group","volume":"73","author":"Cox","year":"1996","journal-title":"Br J Cancer"},{"key":"2024021702390485000_llad394-B14","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0190-9622(84)70090-9","article-title":"Chronic solar ultraviolet damage associated with malignant melanoma of the skin","volume":"10","author":"Schreiber","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"2024021702390485000_llad394-B15","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1524-4725.1988.tb03588.x","article-title":"Epidemiology of malignant melanoma: intermittent or total accumulated exposure to the sun?","volume":"14","author":"Armstrong","year":"1988","journal-title":"J Dermatol Surg Oncol"},{"key":"2024021702390485000_llad394-B16","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.jaad.2019.01.044","article-title":"Age as key factor for pattern, timing, and extent of distant metastasis in patients with cutaneous melanoma: a study of the German Central Malignant Melanoma Registry","volume":"80","author":"Gassenmaier","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"2024021702390485000_llad394-B17","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.0022-202X.2005.23852.x","article-title":"Increasing incidence of lentigo maligna melanoma subtypes: northern California and national trends 1990\u20132000","volume":"125","author":"Swetter","year":"2005","journal-title":"J Invest Dermatol"},{"key":"2024021702390485000_llad394-B18","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/jamadermatol.2020.0470","article-title":"Evaluation of sex-specific incidence of melanoma","volume":"156","author":"Olsen","year":"2020","journal-title":"JAMA Dermatol"},{"key":"2024021702390485000_llad394-B19","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/ajd.12928","article-title":"The steadily growing problem of lentigo maligna and lentigo maligna melanoma in Australia: population-based data on diagnosis and management","volume":"60","author":"Guitera","year":"2019","journal-title":"Australas J Dermatol"},{"key":"2024021702390485000_llad394-B20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2133.1988.tb01751.x","article-title":"Oestrogen and progesterone receptors in lentigo maligna","volume":"118","author":"Sawaya","year":"1988","journal-title":"Br J Dermatol"},{"key":"2024021702390485000_llad394-B21","doi-asserted-by":"crossref","first-page":"e31770","DOI":"10.7554\/eLife.31770","article-title":"Activation of G protein-coupled estrogen receptor signaling inhibits melanoma and improves response to immune checkpoint blockade","volume":"7","author":"Natale","year":"2018","journal-title":"eLife"},{"key":"2024021702390485000_llad394-B22","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1111\/jdv.15348","article-title":"Gender differences, UV exposure and risk of lentigo maligna in a nationwide healthcare population cohort study","volume":"33","author":"Higgins","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2024021702390485000_llad394-B23","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/sj.jid.5701058","article-title":"UV radiation-induced immunosuppression is greater in men and prevented by topical nicotinamide","volume":"128","author":"Damian","year":"2008","journal-title":"J Invest Dermatol"},{"key":"2024021702390485000_llad394-B24","author":"van Bodegraven"},{"key":"2024021702390485000_llad394-B25","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/ijd.14334","article-title":"Increasing incidence of lentigo maligna and lentigo maligna melanoma in Catalonia","volume":"58","author":"Matas-Nadal","year":"2019","journal-title":"Int\u00a0J Dermatol"},{"key":"2024021702390485000_llad394-B26","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/j.jid.2016.06.014","article-title":"Epidemiology of lentigo maligna and lentigo maligna melanoma in the Netherlands, 1989\u20132013","volume":"136","author":"Greveling","year":"2016","journal-title":"J Invest Dermatol"},{"key":"2024021702390485000_llad394-B27","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jaad.2018.07.041","article-title":"Cutaneous malignant melanoma incidence and mortality trends in Canada: a comprehensive population-based study","volume":"80","author":"Ghazawi","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"2024021702390485000_llad394-B28","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejca.2017.12.024","article-title":"Trends in incidence of thick, thin and in situ melanoma in Europe","volume":"92","author":"Sacchetto","year":"2018","journal-title":"Eur J Cancer"},{"key":"2024021702390485000_llad394-B29","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.molonc.2011.03.002","article-title":"Evolving concepts in melanoma classification and their relevance to multidisciplinary melanoma patient care","volume":"5","author":"Scolyer","year":"2011","journal-title":"Mol Oncol"},{"key":"2024021702390485000_llad394-B30","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1111\/bjd.13204","article-title":"Clinicopathological characteristics of 270 patients with lentigo maligna and lentigo maligna melanoma: data from a German skin cancer centre","volume":"171","author":"Gambichler","year":"2014","journal-title":"Br J Dermatol"},{"key":"2024021702390485000_llad394-B31","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1529-8019.2008.00244.x","article-title":"Lentigo maligna","volume":"21","author":"Smalberger","year":"2008","journal-title":"Dermatol Ther"},{"key":"2024021702390485000_llad394-B32","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0738-081X(02)00221-3","article-title":"Dermatoscopy for facial pigmented skin lesions","volume":"20","author":"Stolz","year":"2002","journal-title":"Clin Dermatol"},{"key":"2024021702390485000_llad394-B33","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jaad.2016.08.032","article-title":"Correlation between digital epiluminescence microscopy parameters and histopathological changes in lentigo maligna and solar lentigo: a dermoscopic index for the diagnosis of lentigo maligna","volume":"76","author":"Annessi","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"2024021702390485000_llad394-B34","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1038\/jid.2010.84","article-title":"The impact of in vivo reflectance confocal microscopy on the diagnostic accuracy of lentigo maligna and equivocal pigmented and nonpigmented macules of the face","volume":"130","author":"Guitera","year":"2010","journal-title":"J Invest Dermatol"},{"key":"2024021702390485000_llad394-B35","doi-asserted-by":"crossref","first-page":"380","DOI":"10.5114\/pdia.2014.40961","article-title":"The use of reflectance confocal microscopy for examination of benign and malignant skin tumors","volume":"31","author":"Wielowieyska-Szybi\u0144ska","year":"2014","journal-title":"Postepy Dermatol Alergol"},{"key":"2024021702390485000_llad394-B36","doi-asserted-by":"crossref","first-page":"e81205","DOI":"10.1371\/journal.pone.0081205","article-title":"Learning reflectance confocal microscopy of melanocytic skin lesions through histopathologic transversal sections","volume":"8","author":"Braga","year":"2013","journal-title":"PLOS ONE"},{"key":"2024021702390485000_llad394-B37","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jaad.2012.10.041","article-title":"Desmoplastic melanoma: a review","volume":"68","author":"Chen","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"2024021702390485000_llad394-B38","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/his.14312","article-title":"PRAME immunohistochemistry as an adjunct for diagnosis and histological margin assessment in lentigo maligna","volume":"78","author":"Gradecki","year":"2021","journal-title":"Histopathology"},{"key":"2024021702390485000_llad394-B39","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1524-4725.2009.01432.x","article-title":"Immunostaining in Mohs micrographic surgery: a review","volume":"36","author":"Tal AK","year":"2010","journal-title":"Dermatol Surg"},{"key":"2024021702390485000_llad394-B40","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4103\/0974-2077.44174","article-title":"Techniques of skin biopsy and practical considerations","volume":"1","author":"Nischal","year":"2008","journal-title":"J Cutan Aesthet Surg"},{"key":"2024021702390485000_llad394-B41","author":"National Institute for Health and Care Excellence"},{"key":"2024021702390485000_llad394-B42","doi-asserted-by":"crossref","first-page":"e301","DOI":"10.1097\/GOX.0000000000000272","article-title":"An assessment of histological margins and recurrence of melanoma in situ","volume":"3","author":"Joyce","year":"2015","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"2024021702390485000_llad394-B43","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1001\/archderm.140.5.552","article-title":"Management of lentigo maligna and lentigo maligna melanoma with staged excision: a 5-year follow-up","volume":"140","author":"Bub","year":"2004","journal-title":"Arch Dermatol"},{"key":"2024021702390485000_llad394-B44","first-page":"395","article-title":"Mohs surgery for the treatment of melanoma in situ: a review","volume":"33","author":"Dawn","year":"2007","journal-title":"Dermatol Surg"},{"key":"2024021702390485000_llad394-B45","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jaad.2019.01.051","article-title":"Comparison of surgical margins for lentigo maligna versus melanoma in situ","volume":"81","author":"Kunishige","year":"2019","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"2024021702390485000_llad394-B46","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1001\/jamadermatol.2013.2301","article-title":"Improving management and patient care in lentigo maligna by mapping with in vivo confocal microscopy","volume":"149","author":"Guitera","year":"2013","journal-title":"JAMA Dermatol"},{"key":"2024021702390485000_llad394-B47","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/09546634.2019.1690624","article-title":"Mohs surgery for the treatment of lentigo maligna and lentigo maligna melanoma \u2013 a systematic review","volume":"32","author":"Sharma","year":"2021","journal-title":"J Dermatol Treat"},{"key":"2024021702390485000_llad394-B48","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/DSS.0000000000000248","article-title":"Five-year outcomes of wide excision and Mohs micrographic surgery for primary lentigo maligna in an academic practice cohort","volume":"41","author":"Hou","year":"2015","journal-title":"Dermatol Surg"},{"key":"2024021702390485000_llad394-B49","first-page":"690","article-title":"Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma using Mel-5 immunostaining: University of Minnesota experience","volume":"32","author":"Bhardwaj","year":"2006","journal-title":"Dermatol Surg"},{"key":"2024021702390485000_llad394-B50","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/jdv.18880","article-title":"Lentigo maligna (melanoma): a systematic review and meta-analysis on surgical techniques and presurgical mapping by reflectance confocal microscopy","volume":"37","author":"Elshot","year":"2023","journal-title":"Acad Dermatol Venereol"},{"key":"2024021702390485000_llad394-B51","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/DSS.0000000000003436","article-title":"Commentary on \u201cRecurrence rate for melanoma excised by Mohs micrographic surgery without immunostaining\u201d","volume":"48","author":"Bennett","year":"2022","journal-title":"Dermatol Surg"},{"key":"2024021702390485000_llad394-B52","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/DSS.0000000000003280","article-title":"Immunostained frozen sections vs traditional permanent paraffin sections for lentigo maligna treated with Mohs micrographic surgery","volume":"48","author":"Punchihewa","year":"2022","journal-title":"Dermatol Surg"},{"key":"2024021702390485000_llad394-B53","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jaad.2007.02.011","article-title":"Staged excision versus Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma","volume":"57","author":"Walling","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"2024021702390485000_llad394-B54","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1001\/archdermatol.2011.2155","article-title":"Geometric staged excision for the treatment of lentigo maligna and lentigo maligna melanoma: a long-term experience with literature review","volume":"148","author":"Abdelmalek","year":"2012","journal-title":"Arch Dermatol"},{"key":"2024021702390485000_llad394-B55","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/S0161-6420(03)00670-5","article-title":"Mapped serial excision for periocular lentigo maligna and lentigo maligna melanoma","volume":"110","author":"Malhotra","year":"2003","journal-title":"Ophthalmology"},{"key":"2024021702390485000_llad394-B56","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1001\/archderm.140.9.1087","article-title":"Surgical margins for lentigo maligna and lentigo maligna melanoma: the technique of mapped serial excision","volume":"140","author":"Huilgol","year":"2004","journal-title":"Arch Dermatol"},{"key":"2024021702390485000_llad394-B57","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1111\/jdv.17135","article-title":"Lentiginous melanoma (lentigo maligna and lentigo maligna melanoma) in Australia: clinicopathological characteristics, management and recurrence rates after 10-year follow-up at a tertiary centre","volume":"35","author":"Collgros","year":"2021","journal-title":"Acad Dermatol Venereol"},{"key":"2024021702390485000_llad394-B58","author":"The Cancer Council Australia, Australian Cancer Network, Ministry of Health, New Zealand"},{"key":"2024021702390485000_llad394-B59","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/bjd.12611","article-title":"Radiotherapy for lentigo maligna: a literature review and recommendations for treatment","volume":"170","author":"Fogarty","year":"2014","journal-title":"Br J Dermatol"},{"key":"2024021702390485000_llad394-B60","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1038\/sj.jid.5700286","article-title":"The small antitumoral immune response modifier imiquimod interacts with adenosine receptor signaling in a TLR7- and TLR8-independent fashion","volume":"126","author":"Sch\u00f6n","year":"2006","journal-title":"J Invest Dermatol"},{"key":"2024021702390485000_llad394-B61","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/bjd.15112","article-title":"Effect of topical imiquimod as primary treatment for lentigo maligna: the LIMIT-1 study","volume":"176","author":"Marsden","year":"2017","journal-title":"Br J Dermatol"},{"key":"2024021702390485000_llad394-B62","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1080\/09546634.2021.1962001","article-title":"Clinical and histologic features associated with lentigo maligna clearance after imiquimod treatment","volume":"33","author":"Kwak","year":"2022","journal-title":"J Dermatolog Treat"},{"key":"2024021702390485000_llad394-B63","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/jdv.14085","article-title":"A systematic review on the role of imiquimod in lentigo maligna and lentigo maligna melanoma: need for standardization of treatment schedule and outcome measures","volume":"31","author":"Tio","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2024021702390485000_llad394-B64","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1001\/jamadermatol.2023.1494","article-title":"Risk of mortality after a diagnosis of melanoma in situ","volume":"159","author":"Patel","year":"2023","journal-title":"JAMA Dermatol"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llad394\/54703040\/llad394.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/49\/3\/218\/56679055\/llad394.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/49\/3\/218\/56679055\/llad394.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T02:39:39Z","timestamp":1708137579000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/49\/3\/218\/7422204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,15]]},"references-count":64,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,11,15]]},"published-print":{"date-parts":[[2024,2,14]]}},"URL":"https:\/\/doi.org\/10.1093\/ced\/llad394","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,3]]},"published":{"date-parts":[[2023,11,15]]}}}